medline.ch Dermatologie Psoriasis

	Meta-Analysis of Long-Term Major Adverse Cardiovascular Events of Different Biologics in Psoriatic Patients. Am J Ther Liu Z, Liao C, Zhou Q, Wang Y, Yin Z. PMID: 42875855 [PubMed - as supplied by publisher]
	Real-world adherence to biologic therapies targeting interleukin 17, interleukin 23 and ustekinumab in moderate-to-severe psoriasis: A multicenter cohort study. Farm Hosp Calvo-Arbeloa M, Miguel-Elcano RS, Arrondo-Velasco A, Sarobe-Carricas M, Borrás-Blasco J. PMID: 42875349 [PubMed - as supplied by publisher]
	Genetic and tissue-level analyses prioritize HDL-associated apolipoprotein M in psoriasis. J Lipid Res Zha S, Wang W, Li L, Wu Y, Wang X, Sun L. PMID: 42874871 [PubMed - as supplied by publisher]
	Errors in Incidence Rates and Other Numbers in Study of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis. JAMA Dermatol Al-Janabi A. PMID: 42873516 [PubMed - as supplied by publisher]
	Temporomandibular disorders in women with psoriatic arthritis by history of psoriasis: a cross-sectional study. Rheumatol Int Yekkalam N, Wänman A, Isacsson G, Canbek A, Rizk M. PMID: 42873288 [PubMed - indexed for MEDLINE]
	The active immune role of keratinocytes: from passive targets to key hubs in psoriatic inflammation. Front Immunol Pei Y. PMID: 42871309 [PubMed - indexed for MEDLINE]
	Clinical Implications of Interleukin-17 as a Hepato-Dermal Link in Patients With Psoriasis and Concomitant Steatotic Liver Disease. J Cutan Med Surg Dupuis EC, Fleming P, Abou Zeinab R, Hartley B, Barakat M, Grewal P. PMID: 42870655 [PubMed - as supplied by publisher]
	Distinct Gut Microbiota Signatures are Associated With Progression of Atherosclerosis in Patients With Psoriasis: Results From the EDSAP Study. Br J Dermatol Abbad-Jaime de Aragón C, Berna-Rico E, Neria F, Perez-Bootello J, Davó-Mogica M, Treichel A, Monge D, Ballester-Martínez MA, Pindado-Ortega C, Castellanos-González M, Llamas-Velasco M, Solís J, Fernández-Friera L, Barderas MG, Pérez-Brocal V, Artacho A, Moya A, Jaén P, Mehta NN, Blauvelt A, Serrano-Villar S, Moreno-Arrones ÓM, González-Cantero Á. PMID: 42870427 [PubMed - as supplied by publisher]
	Obesity and Early Biologic Failure in Psoriasis: An Italian Multicentre Retrospective Cohort Study. Dermatol Ther (Heidelb) Tartaglia J, Donini M, Garbo C, Gatti A, Gisondi P, Romagnolo N, Schiesari L, Piaserico S. PMID: 42870207 [PubMed - as supplied by publisher]
	Eczema-Psoriasis Overlap: An eDelphi Consensus on Clinical Presentation and Therapeutic Management Among Italian Experts. Dermatol Ther (Heidelb) De Luca E, Campanati A, Galluzzo M, Gori N, Megna M, Napolitano M, Rech G, Caldarola G. PMID: 42870206 [PubMed - as supplied by publisher]
	Correction: Effectiveness and Safety of ILâ€‘17A Inhibitors in Pediatric Psoriasis: A Realâ€‘World, Multicenter, International Study. Paediatr Drugs Di Lernia V, Bonniaud B, Puzenat E, Bodemer C, Seyler M, Seyger MMB, Tardieu M, Iznardo H, Satolli F, Luna PC, Carpentier O, Hocar O, Torres T, Neri I, Stingeni L, Bertoli C, Beauchet A, Mahé E, GrPso, GR SFDP, Secu-Ped Investigators. PMID: 42870136 [PubMed - as supplied by publisher]
	Dysfunctional tight junctions in psoriasis pathogenesis: mechanisms and therapeutic implications. Cell Signal Zhou L, Hou H, Han Q, Hou R, Niu X. PMID: 42869320 [PubMed - as supplied by publisher]
	Persistent Gaps in Inclusion of Racial and Ethnic Minorities in Nail Psoriasis Randomized Clinical Trials: A Systematic Review. Cutis Chalupczak NV, Ricardo JW, Lipner SR. PMID: 42868304 [PubMed - in process]
	Psoriasis Area and Severity Index Use in Pediatric Psoriasis. Cutis Patra P, Parker L, Albers S. PMID: 42868296 [PubMed - indexed for MEDLINE]
	Smoking Status and Psoriasis Risk: An Updated Systematic Review and Meta-Analysis. Dermatology Ye Y, Lim JJ, Huang Z, Chew FT. PMID: 42868059 [PubMed - as supplied by publisher]
	Frequency and Clinicohistopathological Concordance of Psoriasis and Psoriasiform Dermatitis: A Tertiary Care Study. Cureus Raghuvanshi R, Shashikant, Ali M, Meena HS, Sukheja C, Gupta I. PMID: 42866419 [PubMed]
	Comparative drug survival of biologic classes in psoriasis: a Japanese single-centre cohort study. Eur J Dermatol Watabe D, Tsunoda K, Hamabata A, Goto M, Yoshioka W, Amano H. PMID: 42862174 [PubMed - indexed for MEDLINE]
	Biologic treatments for palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta-analysis. Eur J Dermatol Ayén-Rodríguez A, Ruiz-Villaverde R, Husein-Elahmed H. PMID: 42862173 [PubMed - indexed for MEDLINE]
	Effects of Switching From Deucravacitinib to Tildrakizumab in Psoriasis: A 28-Week Real-World Study. J Psoriasis Psoriatic Arthritis Takahashi Y, Hagino T, Yoneyama M, Shiba M, Saeki H, Fujimoto E, Kanda N. PMID: 42861124 [PubMed - as supplied by publisher]
	Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies. Rheumatology (Oxford) Deodhar A, Gottlieb AB, Merola JF, Soriano ER, Coates LC, Ink B, Bajracharya R, Healy P, Mease PJ. PMID: 42860055 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 28643

Seite 1 von 1433

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung